Cancer:
​
-
Development of PKI targeting Npm-ALK and the study of conformational plasticity and binding kinetics.
​
-
How kinases define specificity in lipid signaling. (Ambizione).
​
-
Inhibitory therapeutics for treatment of autoimmune disorders.
Neglected/Orphan disease:
​
-
Pre-clinical evaluation of Rimeporide, NHE1 inhibitor and drug repurposing in Duchenne muscular dystrophy.​
​​
-
Targeting RNA stem-loop structure regulating the alternative splicing of SMN2: a new therapeutic target in Spinal Muscular Atrophy.
​​
-
Identifying and developing new therapeutic concepts for the treatment of neglected diseases.
-
Scaffolds for Alternative Delivery (SADEL) for IBD.
​
​
​
Antibiotics:
​
-
Identification and characterization of novel antibacterial compounds using protozoan hosts.